שולי רווח נקי: Anbio Biotechnology (NNNN)

Anbio Biotechnology retains leading scientists through the rapid implementation of developments, while management focuses on obtaining medical certifications. Net profit margins demonstrate profit resilience against costs, with the current metric standing at 73.80. Efficient distribution of tests and strict temperature control ensure operational profitability and minimize resource deficits.
פילוחי נתונים אנליטיים מרוכזים עבור Anbio Corp (NNNN)

Sales margins determine the share of net profit in revenue, reflecting cost management efficiency and the final profitability of each unit of income. By analyzing the integral net margin indicator, an investor can observe capital dynamics, which for Anbio Biotechnology (NNNN) confirms high operational resilience driven by stable demand for diagnostic systems and regular medical procurement.